UK Markets closed

Vetoquinol SA (0O1O.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
80.75+0.60 (+0.75%)
At close: 06:13PM BST
Full screen
Previous close80.15
Open80.75
Bid0.00 x 0
Ask0.00 x 0
Day's range80.75 - 80.75
52-week range80.75 - 80.75
Volume6
Avg. volumeN/A
Market cap944.549M
Beta (5Y monthly)0.67
PE ratio (TTM)23.66
EPS (TTM)3.41
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Vetoquinol 2022 Half Year Results: Additional Information on the Group’s Strategy

    LURE, France, September 23, 2022--Regulatory News: Following the conference call organised on 15 September 2022 to present its half-year results, Vetoquinol (Paris:VETO) would like to provide some additional information on the strategy implemented and its outlook.

  • Business Wire

    Vetoquinol: 2022 Half Year Results

    LURE, France, September 15, 2022--Regulatory News: Matthieu Frechin, CEO of Vetoquinol (Paris:VETO), said: "In an uncertain environment (Russian-Ukrainian conflict, rising inflation and a slowdown in the global animal health market), our laboratory continues to grow, driven by the momentum of our Essential products. Our new strategic plan "Ambition 2026" continues and reinforces the changes made over the last 10 years. It is based on 3 pillars: accentuating our focus (species, segments and marke

  • Business Wire

    Vetoquinol: H1 2022 Sales: €271m, up 6.1%

    LURE, France, July 20, 2022--Regulatory News: Matthieu Frechin, Chief Executive Officer of Vetoquinol (Paris:VETO), said: "In a global animal health market that is normalising after two years of exceptional growth, our laboratory is continuing to expand, driven by our strategy of focusing on our Essential products and on the most promising territories. Our recent launches, combined with a large-scale marketing plan, offer us solid prospects. As a result, we expect to continue to grow at a sustai